英文别名:
Levonorgestrel;13-ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one;13-ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one;13-ethyl-17-hydroxy-19-dinor-17-alpha-pregn-4-en-20-yn-3-on(+)-1;17-alpha-ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one;17-beta-hydroxy-18-methyl-19-nor-17-alpha-pregn-4-en-20-yn-3-one;17-ethynyl-18-methyl-19-nortestosteron;17-ethynyl-18-methyl-19-nortestosterone;18-methyl-17-alpha-ethynyl-19-nortestosterone;(-)-Norgestrel;[18,19-Dinorpregn-4-en-20-yn-3-one-13-ethyl-17-hydroxy-,(17.α.)-(-)-];D-(-)-Norgestrel;D(−)-Norgestrel;D-Norgestrel;(-)-18,19-Dinor-13β-ethyl-17β-hydroxy-4-pregnen-20-yn-3-one;(-)-17α-Ethynyl-18-methyl-19-nortestosterone;(-)-Levonorgestrel;D(-)-13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one;norgestrel;Microval;Levonova;Postinor;Mirena;Ovrette;Neogest;Jadelle;Plan B;NORPLANT;Norplant 2;Microlution;Follistrel;Triciclor;Microgyn;Trivora;Monovar;Ovranette;Triagynon;Microlut;Nordet;Trigoa;18-Methylnorethisterone;Levonorgestrelum;Microgynon CD;Microgest ED;Norplant II;Ovral-Lo;Logynon ED;Levlen ED;Trinordiol 28;Trinordiol 21;Microgynon 28;Microgynon 21;d(-)-Norgestrel;Monofeme 28;Neogynon 21;Nordette 28;Minivlar 30;Stediril 30;Nordette ;(17α)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one (ACI);18,19-Dinor-17α-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy- (7CI, 8CI);13-Ethyl-17-ethynyl-17β-hydroxy-4-gonen-3-one;13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one;13-Ethyl-17α-ethynyl-17-hydroxygon-4-en-3-one;13-Ethyl-17α-ethynylgon-4-en-17β-ol-3-one;13β-Ethyl-17α-ethynyl-17β-hydroxygon-4-en-3-one;17α-Ethynyl-13-ethyl-19-nortestosterone;17α-Ethynyl-13β-ethyl-3-oxo-4-estren-17β-ol;17α-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one;17α-Ethynyl-18-homo-19-nortestosterone;17α-Ethynyl-18-methyl-19-nortestosterone;17β-Hydroxy-18-methyl-19-nor-17α-pregn-4-en-20-yn-3-one;18-Methyl-17α-ethynyl-19-nortestosterone;18-Methylnorethindrone;19-Nortestosterone, 17-ethynyl-18-methyl-;d-(17α)-17-Hydroxy-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one;Dexnorgestrel;Femilis;Femilis Slim;Jaydess;Lng-IUS;MeSH ID: D016912;Microluton;Norgeston;Norgestrelem;Norlevo;Plan B One-Step;Postinor 2;Sino-implant (II);Skyla;Wy 5104;Levonorgestrel for system suitability 2;Levonorgestrel for system suitability 1;NSC-757251;alpha-Norgestrel;LESSINA COMPONENT LEVONORGESTREL;SEASONIQUE COMPONENT LEVONORGESTREL;ELIFEMME COMPONENT LEVONORGESTREL;NORGESTREL COMPONENT OF OVRAL;17-Ethynyl-18-methyl-19-nortestosterone Glucuronide; Levonorgestrel Glucuronide;;HMS2097K08;CCRIS 6525;OVRAL COMPONENT NORGESTREL;Tri-Levlen 21;BSPBio_000846;DTXCID1016496;C08149;Prestwick0_000773;Levonorgestrel (JAN/USP/INN);13beta-ethyl-17alpha-ethynyl-17-hydroxy-gon-4-en-3-one;Wy-3707;Ovrette (TN);HSDB 3595;Plan B One Step;Prestwick_109;5W7SIA7YZW;Norgestrel [USAN:USP:INN:BAN:JAN];NORGESTREL [JAN];CHEMBL1389;6533-00-2;BCP9000852;HMS3714K08;HY-B0257;DB00367;Levonorgestrel 100 microg/mL in Acetonitrile;CHEBI:50901;13-Ethyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one;KYLEENA COMPONENT LEVONORGESTREL;LEVLITE COMPONENT LEVONORGESTREL;NORGESTREL [USAN];[(-)-13-ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one;LEVONORGESTREL [HSDB];LEVONORGESTREL [USAN];(+/-)-13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE;SH 850;DTXSID3036496;NCGC00256735-01;CHEBI:6443;17alpha-Ethynyl-18-homo-19-nor-testosterone;Triquilar ED;dl-13-beta-Ethyl-17-alpha-ethynyl-17-beta-hydroxygon-4-en-3-one;[18,(17.alpha.)-(-)-];LEVONORGESTREL [MART.];BDBM50410522;18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-;LEVONORGESTREL [EP MONOGRAPH];EINECS 212-349-8;Levonorgestrel, British Pharmacopoeia (BP) Reference Standard;Liletta;NORDETTE COMPONENT LEVONORGESTREL;13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one;PLASTIC IUD WITH LEVONORGESTREL;HMS3649J10;NCGC00159349-05;KURVELO COMPONENT LEVONORGESTREL;NORGESTREL [USP-RS];Levonorgestrel implant;NSC 744007;AFIRMELLE COMPONENT LEVONORGESTREL;(-)-18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one;NORGESTREL [EP MONOGRAPH];LMST02030119;(+/-)-13-ETHYL-17-HYDROXY-18,19-DINOR-17alpha-PREGN-4-EN-20-YN-3-ONE;MYZILRA COMPONENT LEVONORGESTREL;Skyla (TN);UNII-3J8Q1747Z2;18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.ALPHA.)-(+/-)-;EINECS 229-433-5;SH-850;13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one;Levonorgestrel(Levonelle);TRIVORA COMPONENT LEVONORGESTREL;NORGESTREL (MART.);Levonorgestrel (Levonelle);NS00067059;Levora-28;s1727;Levogel;AVIANE COMPONENT LEVONORGESTREL;Oral levonorgestrel;D00950;NCGC00159349-02;D(-)-Norgestrel, analytical standard;NORGESTREL [INN];E-Gen-C;UNII-5W7SIA7YZW;s5709;LEVORA COMPONENT LEVONORGESTREL;Prestwick2_000773;BPBio1_000932;HMS1570K08;SEASONALE COMPONENT LEVONORGESTREL;13-ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one;NORGESTREL [USP MONOGRAPH];ENPRESSE COMPONENT LEVONORGESTREL;Levora-21;TRIPHASIL COMPONENT LEVONORGESTREL;CAS-797-63-7;Levonorgestrel, European Pharmacopoeia (EP) Reference Standard;NS00002177;LEVONORGESTREL [USP MONOGRAPH];SH-70850;LOSEASONIQUE COMPONENT LEVONORGESTREL;(+/-)-NORGESTREL;FH-122A;D00954;Intrauterine levonorgestrel;Tox21_202872;Levonorgestrel implants;SH 70850;NSC-744007;SR-01000759218-5;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one;Next choice;Methylnorethindrone;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;CRYSELLE COMPONENT NORGESTREL;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name);Opera_ID_552;NCGC00260418-01;Wy 3707;Ovoplex 30-150;17alpha-Ethynyl-13-ethyl-19-nortestosterone;IMPLANT WITH LEVONORGESTREL;NCGC00257283-01;(17alpha)-dl-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3- one;dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone;Kyleena;13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;MARLISSA COMPONENT LEVONORGESTREL;Wy-5104;13-ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one;DL Norgestrel;LEVONORGESTREL [WHO-DD];NORGESTREL (EP MONOGRAPH);BRD-K35189033-001-26-1;13beta-ethyl-17alpha-ethynyl-17beta-hydroxy-gon-4-en-3-one;HMS2232H06;dl-Norgestrel;BAY 86-5028;Norgestrel [Progestins];13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one;SETLAKIN COMPONENT LEVONORGESTREL;AKOS015894913;NORGESTREL (-)-FORM [MI];BAY86-5028;LEVONORGESTREL [INN];1lhv;D-(-)-Norgestrel beta-D-Glucuronide;(+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;Microgynon 30 ED;Nordette 21;NORGESTIMATE IMPURITY B [EP IMPURITY];Z1544404028;17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one;MLS000759484;LEVONEST COMPONENT LEVONORGESTREL;NORGESTREL [MART.];HSDB 6483;Norgestrel-(-)-D;ALESSE COMPONENT LEVONORGESTREL;PORTIA COMPONENT LEVONORGESTREL;17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one;HMS3886K18;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)-;N0889;Norgestrelum;797-63-7;(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;NSC 759653;NORGESTREL [VANDF];18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, (17alpha)-(+/-)-;Triphasil 21;SR-01000946725;PREVEN COMPONENT LEVONORGESTREL;LEVONORGESTREL [USP IMPURITY];LEVONORGESTREL [VANDF];MLS001423967;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one;C08153;Tox21_111593;BIDD:PXR0194;HMS2090O06;Levonelle;17alpha-Ethynyl-18-homo-19-nortestosterone;Levonorgestrel, United States Pharmacopeia (USP) Reference Standard;17-alpha-Ethynyl-13-ethyl-19-nortestosterone;Mirena (TN);Norgestrel (JP17/USP/INN);HMS2232K12;GTPL2881;Q416950;NORGESTREL [ORANGE BOOK];(-)-17alpha-Ethynyl-18-methyl-19-nortestosterone;rel-(8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one;MLS000069491;Levonorgestrel, Pharmaceutical Secondary Standard; Certified Reference Material;OPILL;SMR000653526;Tox21_303658;Preven;NSC 757251;ALTAVERA COMPONENT LEVONORGESTREL;17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol;CLIMARA PRO COMPONENT LEVONORGESTREL;DTXCID401079284;Prestwick3_000773;SMR000059117;LD norgestrel [French];SPBio_002785;SR-01000759218;Norgestrel (-)-form;NORGESTREL [MI];LEVONORGESTREL [USP-RS];HMS2051M08;CCRIS 9033;NC00103;Levosert;NCGC00159349-03;SR-01000946725-1;Levonorgestrelum [INN-Latin];(-)-13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE;CAS-6533-00-2;NORGESTREL (USP MONOGRAPH);BRN 2391114;18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.ALPHA.)-(-)-;Trifeme 28;Tox21_111593_1;Norplant (TN);LNG;NORGESTREL COMPONENT OF CRYSELLE;L-4455;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one;NSC744007;CCG-100853;VIENVA COMPONENT LEVONORGESTREL;Norplant System in Plastic Container;18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+-)-;Levonorgestrel for system suitability 2, European Pharmacopoeia (EP) Reference Standard;BRD-K35189033-001-03-0;MFCD00199013;DTXSID3047477;Prestwick1_000773;OPCICON ONE-STEP COMPONENT LEVONORGESTREL;Levonorgestrel [USAN:USP:INN:BAN];18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-;LEVONORGESTREL [WHO-IP];NORGESTREL [WHO-DD];TWIRLA COMPONENT LEVONORGESTREL;Fallback Solo;LEVONORGESTREL [JAN];INTROVALE COMPONENT LEVONORGESTREL;Norgestrel, (-)-;3J8Q1747Z2;Rigevidon 21+7;QUARTETTE COMPONENT LEVONORGESTREL;(1R,3aS,3bR,9aR,9bS,11aS)-11a-ethyl-1-ethynyl-1-hydroxy-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one;QUASENSE COMPONENT LEVONORGESTREL;18,19-Dinor-4-pregnen-20-yn-3-one;ORSYTHIA COMPONENT LEVONORGESTREL;Norgestrelum [INN-Latin];MLS001074069;SCHEMBL27597;NORGESTREL (USP-RS);18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one;Ld norgestrel;NORGESTREL [HSDB];(-)-Norgestrel, 98%;Triphasil 28;LYBREL COMPONENT LEVONORGESTREL;Tox21_303623;LEVONORGESTRELUM [WHO-IP LATIN];dl-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20- yn-3-one;EN300-122613;LEVONORGESTREL [ORANGE BOOK];FH 122-A;